Breast cancer is classified into three molecular subtypes based on the expression of hormone receptors (estrogen receptor, progesterone receptor) and HER2: hormone receptor-positive (HR+), HER2-positive (HER2+), and triple-negative breast cancer (TNBC). This evidence concerns the gene NR4A1 and breast cancer.